Elevance Health Inc.
Elevance Health Reports 2025 Financial Results and 2026 Outlook
Summary
Elevance Health, Inc. reported its fourth quarter and full year 2025 financial results, with total operating revenue of $197.6 billion for the year, an increase of 12.8% compared to 2024. The company also provided its outlook for 2026, projecting at least $25.50 in adjusted diluted earnings per share (EPS). Key financial highlights include a GAAP diluted EPS of $25.21 for 2025 and an adjusted diluted EPS of $30.29. Elevance Health also declared a first quarter 2026 dividend of $1.72 per share, payable on March 25, 2026, to shareholders of record at the close of business on March 10, 2026.
Profitelligence Alerts
Get alerts for ELV
Be first to know when Elevance Health Inc. files with the SEC.
Filing Categories
Advertisement
About Elevance Health Inc.
Elevance Health Inc., formerly known as Anthem, is a prominent health insurance company in the United States. Its primary function is to provide a wide range of health insurance products and related services to a diverse customer base, including individuals, families, and businesses. Elevance Health focuses on enhancing health and well-being by offering managed care plans tailored to the varying needs of its clients. With a robust portfolio, Elevance Health caters to multiple sectors within the healthcare industry, influencing stakeholders such as healthcare providers, pharmaceutical companies, and medical technology firms. The company plays a critical role in the healthcare market by negotiating coverage terms, managing costs, and ensuring policyholders have access to necessary medical services. As one of the largest health insurers in the nation, Elevance Health holds significant market influence, contributing to shaping healthcare policies and practices through its vast network and strategic partnerships. By leveraging technology and data analytics, the company aims to improve patient outcomes, streamline insurance processes, and foster advancements in personalized healthcare solutions.
Official SEC Documents
Advertisement